Corcept Therapeutics (CORT) Other Operating Expenses (2012 - 2026)
Corcept Therapeutics (CORT) posted Other Operating Expenses of $4.1 million for Q2 2026, up 40.86% sequentially from $2.9 million in Q1 2026, and up 18.29% YoY from $3.4 million in Q2 2025.
Corcept Therapeutics (CORT) Other Operating Expenses (2012 - 2026) Analysis & Trends
Corcept Therapeutics has reported Other Operating Expenses for 15 years, with the latest figure at $4.1 million in Q2 2026.
- Quarterly Other Operating Expenses rose 18.29% year-over-year to $4.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $14.1 million (up 20.81% YoY) and the FY2025 annual result came in at $13.0 million, changed N/A from the prior year.
- Other Operating Expenses improved to $4.1 million in Q2 2026 per CORT's latest filing, from $2.9 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $4.6 million in Q3 2025 and troughed at $1.2 million in Q1 2022.
- A 5-year average of $2.4 million and a median of $2.5 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses soared 82.9% in 2024, then dropped 13.9% in 2025.
- Over 5 years, Other Operating Expenses stood at $1.5 million in 2022, then climbed by 26.82% to $1.9 million in 2023, then jumped by 57.49% to $3.0 million in 2024, then decreased by 13.9% to $2.5 million in 2025, then surged by 59.57% to $4.1 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $4.1 million, $2.9 million, and $2.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.06 Mn |
| Mar 31, 2026 | 2.88 Mn |
| Dec 31, 2025 | 2.55 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Dec 31, 2023 | 1.88 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.57 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 1.48 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.28 Mn |